Menu
Back to Journals » Biologics: Targets and Therapy » Volume 15
Biologics: Targets and Therapy
- View all (426)
- Volume 15, 2021 (5)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 15, 2021
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
Mohammadi R, Aryan A, Omrani MD, Ghaderian SMH, Fazeli Z
Biologics: Targets and Therapy 2021, 15:53-59
Published Date: 2 March 2021
Biologic Treatments of Psoriasis: An Update for the Clinician
Brownstone ND, Hong J, Mosca M, Hadeler E, Liao W, Bhutani T, Koo J
Biologics: Targets and Therapy 2021, 15:39-51
Published Date: 16 February 2021
Convalescent Plasma for the Treatment of Severe COVID-19
Franchini M, Liumbruno GM
Biologics: Targets and Therapy 2021, 15:31-38
Published Date: 4 February 2021
Biologic Therapies for Giant Cell Arteritis
Harrington R, Al Nokhatha SA, Conway R
Biologics: Targets and Therapy 2021, 15:17-29
Published Date: 6 January 2021
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
Fitzgerald T, Melsheimer R, Lafeuille MH, Lefebvre P, Morrison L, Woodruff K, Lin I, Emond B
Biologics: Targets and Therapy 2021, 15:1-15
Published Date: 6 January 2021